Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We
hereby consent to the incorporation by reference in the
Registration Statements on Form S-8 (No. 333-167175, 333-196464,
and 333-210182) and on Form S-3 (No. 333-202244, 333-187466, and
333-196468) of our report dated March 16, 2017 included in this
Annual Report on Form 10-K of Tenax Therapeutics, Inc. and
Subsidiary (the “Company”), relating to the
consolidated balance sheets of the Company as of December 31, 2016
and 2015, and the related consolidated statements of operations and
comprehensive loss, stockholders’ equity, and cash flows for
the year ended December 31, 2016, the eight months ended December
31, 2015 and the years ended April 30, 2015 and 2014, and the
effectiveness of internal control over financial reporting for the
Company as of December 31, 2016.
/s/ CHERRY BEKAERT LLP
Raleigh,
North Carolina
March
16, 2017